Skip to main content

Market Overview

Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket

Share:
Why Biophytis Shares Are Trading Higher By 54%; Here Are 20 Stocks Moving Premarket

Gainers

  • Biophytis S.A. (NASDAQ: BPTS) shares surged 53.9% to $3.31 in pre-market trading after the company signed a partnership with SEQENS to produce Sarconeos (BIO101) active compound, the company's main product.
  • Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares gained 41.8% to $0.3729 in pre-market trading after EMA announced positive feedback on the company's proposed Phase 3 study AR-301 for pneumonia caused by Gram-positive bacteria Staphylococcus aureus in mechanically ventilated hospitalized patients.
  • Karyopharm Therapeutics Inc. (NASDAQ: KPTI) rose 26.1% to $1.93 in pre-market trading after the company received FDA Fast Track Designation for Selinexor for Myelofibrosis.
  • Rubicon Technologies, Inc. (NYSE: RBT) shares rose 19.9% to $0.47 in pre-market trading after surging 19% on Monday.
  • Taoping Inc. (NASDAQ: TAOP) shares gained 14.4% to $0.5999 in pre-market trading after declining 7% on Monday.
  • Vapotherm, Inc. (NYSE: VAPO) shares rose 13.4% to $0.4364 in pre-market trading after gaining 8% on Monday.
  • Healthcare Triangle, Inc. (NASDAQ: HCTI) gained 13.4% to $5.26 in pre-market trading after jumping 27% on Monday.
  • Hitek Global Inc. (NASDAQ: HKIT) rose 11.1% to $6.71 in pre-market trading.
  • iSun, Inc. (NASDAQ: ISUN) shares climbed 10.4% to $0.4350 in pre-market trading.
  • Near Intelligence, Inc. (NASDAQ: NIR) gained 9.3% to $1.86 in pre-market trading. Benchmark recently initiated coverage on the stock with a Speculative Buy rating and announced a $3 price target.

Losers

  • 9 Meters Biopharma, Inc. (NASDAQ: NMTR) fell 59% to $0.2550 in pre-market trading after declining around 8% on Monday.
  • Masimo Corporation (NASDAQ: MASI) fell 27.3% to $106.95 in pre-market trading after the company reported weak preliminary revenue results for the second quarter.
  • CEL-SCI Corporation (NYSE: CVM) fell 22% to $2.23 in pre-market trading after the company priced its public offering of 2.5 million shares at $2 per share.
  • ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares dropped 18.1% to $5.07 in pre-market trading. ProMIS Neurosciences shares jumped 120% on Monday after the company presented preclinical data supporting the potential therapeutic advantage of its lead candidate for AD, PMN310, and additional studies that further characterize a computationally-derived AD vaccine at AAIC 2023.
  • First Wave BioPharma, Inc. (NASDAQ: FWBI) fell 13.6% to $0.7001 in pre-market trading after declining around 15% on Monday.
  • TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares fell 11.5% to $0.4130 in pre-market trading after declining around 10% on Monday.
  • EUDA Health Holdings Limited (NASDAQ: EUDA) fell 11.4% to $0.54 in pre-market trading.
  • Novan, Inc. (NASDAQ: NOVN) fell 11.1% to $0.16 in pre-market. Novan shares declined 70% on Monday after the company announced it entered into an agreement to sell substantially all of its assets and filed for Chapter 11 protection.
  • Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) fell 9.5% to $8.80 in pre-market trading after reporting a proposed public offering of common stock.
  • Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) shares fell 7.1% to $7.00 in pre-market trading. LIXTE Biotechnology shares jumped over 38% on Monday after the company announced results of its collaboration with the Netherlands Cancer Institute that showed LB-100 enhanced the effectiveness of immunotherapy and chemotherapy.

 

Now Read This: Market Volatility Increases Following China Data; S&P 500 Settles Higher

 

Related Articles (ABOS + ARDS)

View Comments and Join the Discussion!

Posted-In: Premarket MoversNews Penny Stocks Small Cap Pre-Market Outlook Markets Movers Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com